Vaccine in Sight, What Now for Stocks?
Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks? Hosted by Simplecast, an AdsWizz company. See…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Trump strikes Russian diesel deal... And Apple’s latest iPhone woes 10/9/26
Stocks Fall As Oil Spikes… And White House CTO On Trump Science Summit 10/8/26
Rates Back On The Rise… And Used Car Market Shifting Into Reverse 10/7/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.